Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Increased β-secretase activity and expression in rats following transient cerebral ischemia

Wen, Yi, Onyewuchi, Otuonye, Yang, Shaohua, Liu, Ran, Simpkins, James W. · 2004 · Brain Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2003.09.086

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Acquati, 2000, The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region, FEBS Lett., 468, 59, 10.1016/S0014-5793(00)01192-3 · DOI
  2. Anderson, 1996, DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay, J. Neurosci., 16, 1710, 10.1523/JNEUROSCI.16-05-01710.1996 · DOI · Paper page
  3. Bederson, 1986, Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats, Stroke, 17, 1304, 10.1161/01.STR.17.6.1304 · DOI · Paper page
  4. Behl, 2000, Apoptosis and Alzheimer's disease, J. Neural Transm., 107, 1325, 10.1007/s007020070021 · DOI · Paper page
  5. Benveniste, 1984, Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis, J. Neurochem., 43, 1369, 10.1111/j.1471-4159.1984.tb05396.x · DOI · Paper page
  6. Bodendorf, 2002, Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid, J. Neurochem., 80, 799, 10.1046/j.0022-3042.2002.00770.x · DOI
  7. Bremer, 1975, Artificial embolization of the middle cerebral artery in primates. Description of an experimental model with extracranial technique, Stroke, 6, 387, 10.1161/01.STR.6.4.387 · DOI
  8. Citron, 2000, Secretases as targets for the treatment of Alzheimer's disease, Mol. Med. Today, 6, 392, 10.1016/S1357-4310(00)01759-7 · DOI
  9. Cotman, 1996, Mechanisms of neuronal death in Alzheimer's disease, Brain Pathol., 6, 493, 10.1111/j.1750-3639.1996.tb00878.x · DOI · Paper page
  10. Farzan, 2000, BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein, Proc. Natl. Acad. Sci. U. S. A., 97, 9712, 10.1073/pnas.160115697 · DOI · Paper page
  11. Fukumoto, 2002, Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol., 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  12. Gasparini, 2002, Does insulin dysfunction play a role in Alzheimer's disease?, Trends Pharmacol. Sci., 23, 288, 10.1016/S0165-6147(02)02037-0 · DOI · Paper page
  13. Ginsberg, 1989, Rodent models of cerebral ischemia, Stroke, 20, 1627, 10.1161/01.STR.20.12.1627 · DOI · Paper page
  14. Gu, 2001, Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch, J. Biol. Chem., 276, 35235, 10.1074/jbc.C100357200 · DOI · Paper page
  15. Holsinger, 2002, Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease, Ann. Neurol., 51, 783, 10.1002/ana.10208 · DOI · Paper page
  16. Hugon, 2000, Apoptosis and Alzheimer disease. Contribution of cellular and transgenic models, Rev. Neurol. (Paris), 156, 123
  17. Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as beta-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
  18. Iizuka, 1996, Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase, Biochem. Biophys. Res. Commun., 218, 238, 10.1006/bbrc.1996.0042 · DOI
  19. Isacson, 2002, Alzheimer's disease and down's syndrome: roles of APP, trophic factors and ACh, Trends Neurosci., 25, 79, 10.1016/S0166-2236(02)02037-4 · DOI · Paper page
  20. Kratzsch, 2002, Etiology and pathogenesis of Alzheimer dementia, Wien Med. Wochenschr., 152, 72, 10.1046/j.1563-258x.2002.01127.x · DOI
  21. LaFerla, 2002, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat. Rev., Neurosci., 3, 862, 10.1038/nrn960 · DOI · Paper page
  22. Li, 1997, Apoptosis and protein expression after focal cerebral ischemia in rat, Brain Res., 765, 301, 10.1016/S0006-8993(97)00524-6 · DOI
  23. Loeb, 1992, Dementia associated with lacunar infarction, Stroke, 23, 1225, 10.1161/01.STR.23.9.1225 · DOI · Paper page
  24. Milward, 1992, The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth, Neuron, 9, 129, 10.1016/0896-6273(92)90228-6 · DOI · Paper page
  25. Murphy, 2001, The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease, NeuroReport, 12, 631, 10.1097/00001756-200103050-00040 · DOI
  26. Nordstedt, 1992, Alzheimer's disease—an amyloid disease of the brain, Lakartidningen, 89, 4255
  27. Nunan, 2000, Regulation of APP cleavage by alpha-, beta- and gamma-secretases, FEBS Lett., 483, 6, 10.1016/S0014-5793(00)02076-7 · DOI · Paper page
  28. Onorato, 1989, Alteration of neuritic cytoarchitecture in Alzheimer disease, Prog. Clin. Biol. Res., 317, 781
  29. Palmert, 1989, The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives, Prog. Clin. Biol. Res., 317, 971
  30. Paola, 2000, Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells, Biochem. Biophys. Res. Commun., 268, 642, 10.1006/bbrc.2000.2164 · DOI
  31. Rao, 2002, Role of oxidative stress and antioxidants in neurodegenerative diseases, Nutr. Neurosci., 5, 291, 10.1080/1028415021000033767 · DOI · Paper page
  32. Rossner, 2001, Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology, J. Neurosci. Res., 64, 437, 10.1002/jnr.1095 · DOI
  33. Saitoh, 1989, Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts, Cell, 58, 615, 10.1016/0092-8674(89)90096-2 · DOI · Paper page
  34. Simpkins, 1997, Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat, J. Neurosurg., 87, 724, 10.3171/jns.1997.87.5.0724 · DOI · Paper page
  35. Sinha, 1999, Purification and cloning of amyloid precursor protein beta-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
  36. Slater, 1995, Signalling mechanisms and oxidative stress in apoptosis, Toxicol. Lett., 82–83, 149, 10.1016/0378-4274(95)03474-9 · DOI · Paper page
  37. Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J. Neurosci., 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997 · DOI · Paper page
  38. Tatemichi, 1994, Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study, Neurology, 44, 1885, 10.1212/WNL.44.10.1885 · DOI · Paper page
  39. Vassar, 2001, The beta-secretase, BACE: a prime drug target for Alzheimer's disease, J. Mol. Neurosci., 17, 157, 10.1385/JMN:17:2:157 · DOI · Paper page
  40. Yan, 2000, Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis, Nat. Med., 6, 643, 10.1038/76216 · DOI · Paper page
  41. Yankner, 1996, New clues to Alzheimer's disease: unraveling the roles of amyloid and tau, Nat. Med., 2, 850, 10.1038/nm0896-850 · DOI

Cited by

See all 188

Metadata

Authors
Wen, Y., Onyewuchi, O., Yang, S., Liu, R., & Simpkins, J. W.
Venue
Brain Research
Publisher
Elsevier BV
Published
2004-05
Volume
1009
Issue
1-2
Pages
1-8
ISSN
0006-8993 (ISSN-L)
OpenAlex
W2164735970
Cited by
188
References
9
FWCI
8.17
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.